PAST EVENT

Psychedelics for Alcoholism

Live Virtual Panel on New Treatments for Alcohol Use Disorder and Binge Drinking

October 20, 2021

The Psychedelic Renaissance is revolutionizing how we treat addiction, and alcoholism is one of the most harmful. In this panel we discussed new treatments for Alcohol Use Disorder and Binge Drinking, with a focus on Clearmind’s MEAI-based medicine.

SPEAKERS

Adi Zuloff-Shani, PhD

CEO, Clearmind

Dr. Adi Zuloff-Shani is a biomedical research and development executive with over 20 years of strategic and operational leadership in the healthcare industry, and a deep understanding of therapeutics development in heavily regulated environments.

Adjunct Prof. Mark Haden

VP Business Development, Clearmind

Previously the Executive Director of MAPS Canada for 10 years, Mark is an adjunct professor at the University of British Columbia's School of Population and Public Health, and has published on the issue of drug control policy and psychedelics. Mark also worked in the addictions field in counselling, supervisory and management positions for 28 years.

Terri Freeland

Construction Industry Professional

Terri has over 20 years of experience in the construction industry in positions, ranging from Project Manager to Co-owner. Terri is personally acquaintanted with people whose lives were impacted by alcohol abuse and with their physical, psychological, and emotional experience with MEAI.

Dr. Jeff Morley

Registered Psychologist

Jeff is a Registered Psychologist and Board Certified Expert in Traumatic Stress. In his practice Jeff works with many first responders and others with PTSD, many of whom are also navigating substance abuse issues. Jeff is himself a retired RCMP officer, having served 23 years in the Royal Canadian Mounted Police (RCMP) and retiring as a Staff Sergeant in 2013.

HOST

Shannon Smadella

Host

Shannon Smadella is an award-winning social entrepreneur and business strategist with deep experience in psychedelic advocacy and organizational leadership. A former board member of MAPS Canada, spokesperson and operations director of World Psychedelics Day, and co-director of the International Psychedelics Awareness Foundation, she has hosted hundreds of interviews with leaders in psychedelic research and policy. She is currently completing her MBA, and oversees community development for Clearmind Medicine.

PARTNERSHIPS